OneHealthdrugs Marathon - ON LINE CA21111 non-stop presentations
20-23 November 2023
OneHealthdrugs Marathon - ON LINE CA21111 non-stop presentations
ONEHEALTHDRUGS FOR ONE HEALTH DAY
Vector-borne parasitic diseases (VBPD) threaten the well-being and health of people and animals across the globe. Because human and veterinary drugs are pivotal in controlling these infections, its widespread use has unintentionally led to their release into the environment, with unpredictable detrimental effects on wildlife and ecosystems. To improve planetary safety and health, we recognise the urgent need for antiparasitic drugs that not only protect humans and animals but also safeguard our ecosystems. Through the EU COST-Action OneHealthdrugs, (CA21111) we are committed to innovate drug development, ensuring precise actions, for the early assessment of the drug environmental impact for optimal drug profiles.
To celebrate the One Health Day, we launch the international event, OneHealthdrugs Marathon that will take place on 20-23rd Nov.
With this event we would like:
to invite all network participants to share their research for the first time from the beginning of our Action and to increase our knowledge of the general research landscape existing in the network;
to attract external and applicant network participants
we also want to generate and transmit a positive feeling of open collaborative atmosphere;
we want to show how new concepts and innovative technologies can be integrated in perspective into all research programs through collaboration, training schools and STSM-COST Action fellowships.
HG4 Young Investigator participation 22 November 2-6pm
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
OneHealthdrugs CA21111
Title:
One Health drugs against parasitic vector borne diseases in Europe and beyond